Vascumab LLC
Doing business as Staten Biotechnology
- UEI
- MNPVA2CY4JY5
- CAGE
- 7B6K5
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Galc pharmacological chaperone drugs for krabbe disease | National Institute of Child Health and Human Development | $273,044 | |
| Small molecule apelin receptor agonists for TEH treatment of heart failure in PAH | National Heart Lung and Blood Institute | $123,462 | |
| Hdac inhibitors for the treatment of pulmonary arterial hypertension | National Heart Lung and Blood Institute | $502,312 |
Quick answers
What is Vascumab LLC's UEI?
Vascumab LLC's Unique Entity ID (UEI) in SAM.gov is MNPVA2CY4JY5.
What is Vascumab LLC's CAGE code?
Vascumab LLC's CAGE code is 7B6K5.
What is Vascumab LLC's primary NAICS code?
Vascumab LLC's primary NAICS code is 541713 (Research and Development in Nanotechnology).
Is Vascumab LLC registered in SAM.gov?
Vascumab LLC's SAM.gov registration expired on December 15, 2021.
What is Vascumab LLC's most recent federal award?
Vascumab LLC's most recent federal grant award is Galc pharmacological chaperone drugs for krabbe disease (R43HD097801), from National Institute of Child Health and Human Development, on May 1, 2019.
On GovTribe
See Vascumab LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors